Approval · Notice of Compliance 37437 · 2026
VOLTAREN: Notice of Compliance 37437
Issued April 29, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37437
- Date
- April 29, 2026
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information. Product Monograph reformatted to the Master Template. Removal of VOLTAREN SR 100mg from the Product Monograph. Update to package insert
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOLTAREN | Not yet assigned | — |
Medicinal ingredients
- DICLOFENAC SODIUM 50 MG per SUP